pharmaceuticals: is expensive

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents industry
Weight: 0.48
, environment
Weight: 0.28
Siblings banking industry
Weight: 0.32
, automobile industry
Weight: 0.32
, chemicals
Weight: 0.31
, electronics
Weight: 0.31
, semiconductor
Weight: 0.30

Related properties

Property Similarity
is expensive 1.00
be expensive in us 0.86
be more expensive in us 0.85
be expensive in states 0.84
be more expensive in europe 0.79
be more expensive in uk 0.79
be costly in india 0.79
is cheap 0.79
be expensive in america 0.79
be expensive in europe 0.79

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.10
Rule weight: 0.13
Evidence weight: 0.96
Similarity weight: 0.79
Evidence: 0.63
¬ Remarkable(pharmaceuticals, is expensive)
Evidence: 0.06
¬ Remarkable(electronics, be more expensive in europe)
0.10
Rule weight: 0.13
Evidence weight: 0.95
Similarity weight: 0.79
Evidence: 0.63
¬ Remarkable(pharmaceuticals, is expensive)
Evidence: 0.07
¬ Remarkable(electronics, be costly in india)
0.10
Rule weight: 0.13
Evidence weight: 0.95
Similarity weight: 0.79
Evidence: 0.63
¬ Remarkable(pharmaceuticals, is expensive)
Evidence: 0.09
¬ Remarkable(electronics, be more expensive in uk)
0.09
Rule weight: 0.13
Evidence weight: 0.90
Similarity weight: 0.79
Evidence: 0.63
¬ Remarkable(pharmaceuticals, is expensive)
Evidence: 0.16
¬ Remarkable(electronics, be expensive in europe)
0.09
Rule weight: 0.13
Evidence weight: 0.70
Similarity weight: 1.00
Evidence: 0.63
¬ Remarkable(pharmaceuticals, is expensive)
Evidence: 0.47
¬ Remarkable(semiconductor, is expensive)

Remarkability from sibling implausibility

0.57
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.87
Plausible(pharmaceuticals, is expensive)
Evidence: 0.47
Remarkable(semiconductor, is expensive)
Evidence: 0.89
¬ Plausible(semiconductor, is expensive)
0.47
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.79
Evidence: 0.87
Plausible(pharmaceuticals, is expensive)
Evidence: 0.06
Remarkable(electronics, be more expensive in europe)
Evidence: 0.05
¬ Plausible(electronics, be more expensive in europe)
0.47
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.79
Evidence: 0.87
Plausible(pharmaceuticals, is expensive)
Evidence: 0.09
Remarkable(electronics, be more expensive in uk)
Evidence: 0.07
¬ Plausible(electronics, be more expensive in uk)
0.47
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.79
Evidence: 0.87
Plausible(pharmaceuticals, is expensive)
Evidence: 0.07
Remarkable(electronics, be costly in india)
Evidence: 0.07
¬ Plausible(electronics, be costly in india)
0.46
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.79
Evidence: 0.87
Plausible(pharmaceuticals, is expensive)
Evidence: 0.16
Remarkable(electronics, be expensive in europe)
Evidence: 0.21
¬ Plausible(electronics, be expensive in europe)

Salient implies Plausible

0.25
Rule weight: 0.28
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.87
Plausible(pharmaceuticals, is expensive)
Evidence: 0.94
¬ Salient(pharmaceuticals, is expensive)

Similarity expansion

0.70
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.86
Evidence: 0.94
Salient(pharmaceuticals, is expensive)
Evidence: 0.79
¬ Salient(pharmaceuticals, be expensive in us)
0.69
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.85
Evidence: 0.94
Salient(pharmaceuticals, is expensive)
Evidence: 0.65
¬ Salient(pharmaceuticals, be more expensive in us)
0.69
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.86
Evidence: 0.92
Typical(pharmaceuticals, is expensive)
Evidence: 0.72
¬ Typical(pharmaceuticals, be expensive in us)
0.68
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.84
Evidence: 0.94
Salient(pharmaceuticals, is expensive)
Evidence: 0.79
¬ Salient(pharmaceuticals, be expensive in states)
0.68
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.85
Evidence: 0.92
Typical(pharmaceuticals, is expensive)
Evidence: 0.70
¬ Typical(pharmaceuticals, be more expensive in us)
0.67
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.84
Evidence: 0.92
Typical(pharmaceuticals, is expensive)
Evidence: 0.73
¬ Typical(pharmaceuticals, be expensive in states)
0.67
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.86
Evidence: 0.87
Plausible(pharmaceuticals, is expensive)
Evidence: 0.69
¬ Plausible(pharmaceuticals, be expensive in us)
0.67
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.85
Evidence: 0.87
Plausible(pharmaceuticals, is expensive)
Evidence: 0.61
¬ Plausible(pharmaceuticals, be more expensive in us)
0.65
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.84
Evidence: 0.87
Plausible(pharmaceuticals, is expensive)
Evidence: 0.69
¬ Plausible(pharmaceuticals, be expensive in states)
0.63
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.79
Evidence: 0.94
Salient(pharmaceuticals, is expensive)
Evidence: 0.95
¬ Salient(pharmaceuticals, be expensive in america)
0.62
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.79
Evidence: 0.92
Typical(pharmaceuticals, is expensive)
Evidence: 0.97
¬ Typical(pharmaceuticals, be expensive in america)
0.59
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.79
Evidence: 0.87
Plausible(pharmaceuticals, is expensive)
Evidence: 0.91
¬ Plausible(pharmaceuticals, be expensive in america)
0.59
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.85
Evidence: 0.63
Remarkable(pharmaceuticals, is expensive)
Evidence: 0.51
¬ Remarkable(pharmaceuticals, be more expensive in us)
0.55
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.86
Evidence: 0.63
Remarkable(pharmaceuticals, is expensive)
Evidence: 0.67
¬ Remarkable(pharmaceuticals, be expensive in us)
0.54
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.84
Evidence: 0.63
Remarkable(pharmaceuticals, is expensive)
Evidence: 0.65
¬ Remarkable(pharmaceuticals, be expensive in states)
0.54
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.79
Evidence: 0.63
Remarkable(pharmaceuticals, is expensive)
Evidence: 0.54
¬ Remarkable(pharmaceuticals, be expensive in america)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.94
Salient(pharmaceuticals, is expensive)
Evidence: 0.92
¬ Typical(pharmaceuticals, is expensive)
Evidence: 0.63
¬ Remarkable(pharmaceuticals, is expensive)

Typical implies Plausible

0.42
Rule weight: 0.48
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.87
Plausible(pharmaceuticals, is expensive)
Evidence: 0.92
¬ Typical(pharmaceuticals, is expensive)

Typicality and Rermarkability incompatibility between siblings

0.09
Rule weight: 0.14
Evidence weight: 0.81
Similarity weight: 0.79
Evidence: 0.63
¬ Remarkable(pharmaceuticals, is expensive)
Evidence: 0.29
¬ Typical(electronics, be more expensive in europe)
0.09
Rule weight: 0.14
Evidence weight: 0.80
Similarity weight: 0.79
Evidence: 0.63
¬ Remarkable(pharmaceuticals, is expensive)
Evidence: 0.31
¬ Typical(electronics, be more expensive in uk)
0.08
Rule weight: 0.14
Evidence weight: 0.79
Similarity weight: 0.79
Evidence: 0.63
¬ Remarkable(pharmaceuticals, is expensive)
Evidence: 0.34
¬ Typical(electronics, be costly in india)
0.07
Rule weight: 0.14
Evidence weight: 0.68
Similarity weight: 0.79
Evidence: 0.63
¬ Remarkable(pharmaceuticals, is expensive)
Evidence: 0.50
¬ Typical(electronics, be expensive in europe)
0.05
Rule weight: 0.14
Evidence weight: 0.39
Similarity weight: 1.00
Evidence: 0.63
¬ Remarkable(pharmaceuticals, is expensive)
Evidence: 0.97
¬ Typical(semiconductor, is expensive)